Table 1.
Parameters | Non-HCV (n = 16,880) |
HCV-Untreated (n = 3376) |
HCV-Treated (n = 1688) |
p Value |
---|---|---|---|---|
Age, years | 51.5 (12.0) | 51.6 (12.0) | 51.4 (11.9) | 0.88 |
Male sex, n (%) | 9130 (54.1) | 1826 (54.1) | 913 (54.1) | >0.99 |
Occupation | <0.0001 | |||
White-collar | 9545 (56.6) | 1439 (42.6) | 709 (42.0) | |
Blue-collar | 6060 (35.9) | 1646 (48.8) | 873 (51.7) | |
Other | 1275 (7.55) | 291 (8.62) | 106 (6.28) | |
Urbanisation | <0.0001 | |||
Urban | 5379 (31.9) | 753 (22.3) | 362 (21.5) | |
Suburban | 8074 (47.8) | 1572 (46.6) | 794 (47.0) | |
Rural | 3427 (20.3) | 1051 (31.1) | 532 (31.5) | |
Geographic region | <0.0001 | |||
Northern | 8015 (47.5) | 1011 (30.0) | 466 (27.6) | |
Central | 3286 (19.5) | 735 (21.8) | 366 (21.7) | |
Southern | 4782 (28.3) | 1429 (42.3) | 764 (45.3) | |
Eastern and outlying islands | 797 (4.72) | 201 (5.95) | 92 (5.45) | |
Monthly Income (NT$) | <0.0001 | |||
<15,840 | 5845 (34.6) | 1008 (29.9) | 437 (25.9) | |
15,840–24,999 | 6431 (38.1) | 1689 (50.0) | 884 (52.4) | |
≥25,000 | 4604 (27.3) | 679 (20.1) | 367 (21.7) | |
Comorbidities | ||||
Myocardial infarction | 2092 (12.4) | 780 (23.1) | 313 (18.5) | <0.0001 |
Cerebrovascular disease | 1182 (7.00) | 454 (13.5) | 184 (10.9) | <0.0001 |
Chronic pulmonary disease | 4025 (23.8) | 1204 (35.7) | 623 (36.9) | <0.0001 |
Diabetes mellitus | 2328 (13.8) | 960 (28.4) | 475 (28.1) | <0.0001 |
Renal disease | 489 (2.90) | 348 (10.3) | 96 (5.69) | <0.0001 |
Hypertension | 4830 (28.6) | 1503 (44.5) | 745 (44.1) | <0.0001 |
Hyperlipidaemia | 1916 (11.4) | 548 (16.2) | 240 (14.2) | 0.002 |
Cataract | 1572 (9.31) | 642 (19.0) | 323 (19.1) | <0.0001 |
Diabetic retinopathy | 242 (1.43) | 112 (3.32) | 39 (2.31) | <0.0001 |
Liver cirrhosis | 2697 (16.0) | 2448 (72.5) | 1537 (91.1) | <0.0001 |
Obesity | 362 (2.14) | 83 (2.46) | 45 (2.67) | 0.24 |
Anemia | 1388 (8.22) | 595 (17.6) | 249 (14.8) | <0.0001 |
Medications | ||||
Statin | 1182 (7.00) | 212 (6.28) | 73 (4.32) | <0.0001 |
Aspirin | 18 (0.11) | 8 (0.24) | 2 (0.12) | 0.15 |
Nonsteroidal anti-inflammatory drugs | 51 (0.30) | 14 (0.41) | 10 (0.59) | 0.11 |
Data are expressed as mean (standard deviation) or number (percentage).